Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study

Andre Mueller, Santiago Bullich, Olivier Barret, Jennifer Madonia, Mathias Berndt, Caroline Papin, Audrey Perrotin, Norman Koglin, Heiko Kroth, Andrea Pfeifer, Gilles Tamagnan, John P Seibyl, Kenneth Marek, Susan de Santi, Ludger M Dinkelborg and Andrew W Stephens
Journal of Nuclear Medicine November 2019, jnumed.119.236224; DOI: https://doi.org/10.2967/jnumed.119.236224
Andre Mueller
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santiago Bullich
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Barret
2 Invicro LLC, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Madonia
2 Invicro LLC, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias Berndt
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Papin
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Perrotin
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman Koglin
3 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heiko Kroth
4 AC Immune SA, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Pfeifer
4 AC Immune SA, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Tamagnan
2 Invicro LLC, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Seibyl
2 Invicro LLC, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Marek
2 Invicro LLC, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan de Santi
5 Life Molecular Imaging Inc, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludger M Dinkelborg
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew W Stephens
1 Life Molecular Imaging GmbH, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.236224
DOI 
https://doi.org/10.2967/jnumed.119.236224
PubMed 
31712323

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 11, 2019.

Article Versions

  • You are currently viewing a previous version of this article (November 11, 2019 - 12:55).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Andre Mueller1,
  2. Santiago Bullich1,
  3. Olivier Barret2,
  4. Jennifer Madonia2,
  5. Mathias Berndt1,
  6. Caroline Papin1,
  7. Audrey Perrotin1,
  8. Norman Koglin3,
  9. Heiko Kroth4,
  10. Andrea Pfeifer4,
  11. Gilles Tamagnan2,
  12. John P Seibyl2,
  13. Kenneth Marek2,
  14. Susan de Santi5,
  15. Ludger M Dinkelborg1 and
  16. Andrew W Stephens1
  1. 1 Life Molecular Imaging GmbH, Germany;
  2. 2 Invicro LLC, United States;
  3. 3 Life Molecular Imaging GmbH, Germany;
  4. 4 AC Immune SA, Switzerland;
  5. 5 Life Molecular Imaging Inc, United States
  1. For correspondence or reprints contact: Andrew W. Stephens, Life Molecular Imaging GmbH, Tegeler Strasse 6-7, Berlin, 13353, Germany. E-mail: a.stephens@life-mi.com

Statistics from Altmetric.com

Cited By...

  • 139 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
    Henrik Zetterberg, Barbara B. Bendlin
    Molecular Psychiatry 2021 26 1
  • Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
    Matthias Brendel, Henryk Barthel, Thilo van Eimeren, Ken Marek, Leonie Beyer, Mengmeng Song, Carla Palleis, Mona Gehmeyr, Urban Fietzek, Gesine Respondek, Julia Sauerbeck, Alexander Nitschmann, Christian Zach, Jochen Hammes, Michael T. Barbe, Oezguer Onur, Frank Jessen, Dorothee Saur, Matthias L. Schroeter, Jost-Julian Rumpf, Michael Rullmann, Andreas Schildan, Marianne Patt, Bernd Neumaier, Olivier Barret, Jennifer Madonia, David S. Russell, Andrew Stephens, Sigrun Roeber, Jochen Herms, Kai Bötzel, Joseph Classen, Peter Bartenstein, Victor Villemagne, Johannes Levin, Günter U. Höglinger, Alexander Drzezga, John Seibyl, Osama Sabri
    JAMA Neurology 2020 77 11
  • Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
    Caitlin Jie, Valerie Treyer, Roger Schibli, Linjing Mu
    Pharmaceuticals 2021 14 2
  • Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, Assunta Ingannato, Deborah Leccese, Valentina Berti, Sonia Padiglioni, Giulia Galdo, Camilla Ferrari, Sandro Sorbi, Valentina Bessi, Benedetta Nacmias
    Journal of Neurology 2022 269 8
  • Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies
    Toshiki Tezuka, Keisuke Takahata, Morinobu Seki, Hajime Tabuchi, Yuki Momota, Mika Shiraiwa, Natsumi Suzuki, Ayaka Morimoto, Tadaki Nakahara, Yu Iwabuchi, Eisuke Miura, Yasuharu Yamamoto, Yasunori Sano, Kei Funaki, Bun Yamagata, Ryo Ueda, Takahito Yoshizaki, Kyoko Mashima, Mamoru Shibata, Munenori Oyama, Kensuke Okada, Masahito Kubota, Hajime Okita, Masaki Takao, Masahiro Jinzaki, Jin Nakahara, Masaru Mimura, Daisuke Ito
    Brain Communications 2021 3 4
  • Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
    Niyatee Samudra, Courtney Lane-Donovan, Lawren VandeVrede, Adam L. Boxer
    Journal of Clinical Investigation 2023 133 12
  • Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
    Madhu Ramesh, Thimmaiah Govindaraju
    Chemical Science 2022 13 46
  • Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
    Leonie Beyer, Alexander Nitschmann, Henryk Barthel, Thilo van Eimeren, Marcus Unterrainer, Julia Sauerbeck, Ken Marek, Mengmeng Song, Carla Palleis, Gesine Respondek, Jochen Hammes, Michael T. Barbe, Özgür Onur, Frank Jessen, Dorothee Saur, Matthias L. Schroeter, Jost-Julian Rumpf, Michael Rullmann, Andreas Schildan, Marianne Patt, Bernd Neumaier, Olivier Barret, Jennifer Madonia, David S. Russell, Andrew W. Stephens, Sigrun Roeber, Jochen Herms, Kai Bötzel, Johannes Levin, Joseph Classen, Günter U. Höglinger, Peter Bartenstein, Victor Villemagne, Alexander Drzezga, John Seibyl, Osama Sabri, Matthias Brendel
    European Journal of Nuclear Medicine and Molecular Imaging 2020 47 12
  • Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
    Gérard N Bischof, Alessandra Dodich, Marina Boccardi, Thilo van Eimeren, Cristina Festari, Henryk Barthel, Oskar Hansson, Agneta Nordberg, Rik Ossenkoppele, Osama Sabri, B Frisoni G Giovanni, Valentina Garibotto, Alexander Drzezga
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 7
  • Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
    Mengmeng Song, Leonie Beyer, Lena Kaiser, Henryk Barthel, Thilo van Eimeren, Ken Marek, Alexander Nitschmann, Maximilian Scheifele, Carla Palleis, Gesine Respondek, Maike Kern, Gloria Biechele, Jochen Hammes, Gèrard Bischof, Michael Barbe, Özgür Onur, Frank Jessen, Dorothee Saur, Matthias L Schroeter, Jost-Julian Rumpf, Michael Rullmann, Andreas Schildan, Marianne Patt, Bernd Neumaier, Olivier Barret, Jennifer Madonia, David S Russell, Andrew W Stephens, Andre Mueller, Sigrun Roeber, Jochen Herms, Kai Bötzel, Adrian Danek, Johannes Levin, Joseph Classen, Günter U Höglinger, Peter Bartenstein, Victor Villemagne, Alexander Drzezga, John Seibyl, Osama Sabri, Guido Boening, Sibylle Ziegler, Matthias Brendel
    Journal of Cerebral Blood Flow & Metabolism 2021 41 11

Article usage

Article usage: November 2019 to April 2025

AbstractFullPdf
Nov 2019799094
Dec 2019245031
Jan 2020205040
Feb 2020147034
Mar 2020160022
Apr 2020137017
May 202093052
Jun 2020105727192
Jul 20202784990
Aug 202015152101
Sep 20202214686
Oct 20201564380
Nov 20201124467
Dec 2020933853
Jan 2021509768
Feb 2021808569
Mar 20216713671
Apr 2021599664
May 20215820486
Jun 20214711864
Jul 20215910669
Aug 2021609748
Sep 20217611275
Oct 202155130126
Nov 202154109106
Dec 20215313065
Jan 20226410469
Feb 20226215177
Mar 20228113878
Apr 20225713067
May 202258162122
Jun 2022328390
Jul 2022307242
Aug 2022406939
Sep 2022306445
Oct 2022355760
Nov 2022306043
Dec 2022274929
Jan 2023396058
Feb 2023277039
Mar 2023479775
Apr 2023415349
May 2023355957
Jun 2023256942
Jul 2023175525
Aug 2023267636
Sep 2023206631
Oct 2023297948
Nov 2023275342
Dec 2023588039
Jan 2024447448
Feb 2024226941
Mar 20242772100
Apr 2024279170
May 2024409851
Jun 2024244531
Jul 2024275330
Aug 2024348793
Sep 20241912158
Oct 20243896188
Nov 2024478763
Dec 2024368943
Jan 2025238760
Feb 20256213954
Mar 20252410562
Apr 20254813664
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
Andre Mueller, Santiago Bullich, Olivier Barret, Jennifer Madonia, Mathias Berndt, Caroline Papin, Audrey Perrotin, Norman Koglin, Heiko Kroth, Andrea Pfeifer, Gilles Tamagnan, John P Seibyl, Kenneth Marek, Susan de Santi, Ludger M Dinkelborg, Andrew W Stephens
Journal of Nuclear Medicine Nov 2019, jnumed.119.236224; DOI: 10.2967/jnumed.119.236224

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
Andre Mueller, Santiago Bullich, Olivier Barret, Jennifer Madonia, Mathias Berndt, Caroline Papin, Audrey Perrotin, Norman Koglin, Heiko Kroth, Andrea Pfeifer, Gilles Tamagnan, John P Seibyl, Kenneth Marek, Susan de Santi, Ludger M Dinkelborg, Andrew W Stephens
Journal of Nuclear Medicine Nov 2019, jnumed.119.236224; DOI: 10.2967/jnumed.119.236224
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • In Vivo Head-to-Head Comparison of [18F]GTP1 with [18F]MK-6240 and [18F]PI-2620 in Alzheimer Disease
  • Assessment and staging of A/T/N with a single dynamic [18F]PI-2620 recording
  • Diagnostic Reference Levels in PET Imaging at Chulabhorn Hospital, Thailand
  • Quantitative PET imaging and modeling of molecular blood-brain barrier permeability
  • Cortical Tau Aggregation Patterns associated with Apraxia in Alzheimer's Disease
  • One-Year Longitudinal Changes in Tau Accumulation on [18F]PI-2620 PET in the Alzheimer Spectrum
  • [18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration
  • Fibril Paint to detect Amyloids and determine Fibril Length
  • PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimers Disease With machine learning: the PREVIEW study protocol
  • Individual regional associations between A{beta}-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
  • Stacked binding of a small molecule PET tracer to Alzheimers tau paired helical filaments
  • Multimodality Imaging in Primary Progressive Aphasia
  • An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • In vivo visualization of propagating {alpha}-synuclein pathologies in mouse and marmoset models by a bimodal imaging probe, C05-05
  • Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers
  • Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Neurology)

  • Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
  • Postinfectious Neurologic Complications in COVID-19: A Complex Case Report
Show more Clinical (Neurology)

Similar Articles

Keywords

  • Neurology
  • PET/CT
  • radiopharmaceuticals
  • Alzheimer’s disease
  • PET
  • PI-2620
  • Positron Emission Tomography
  • tau
SNMMI

© 2025 SNMMI

Powered by HighWire